Nintedanib esylate

Category API

Details	Specifications
CAS Number	656247-18-6
Molecular Formula	C33H39N5O7S
Molecular Weight	649.76 g/mol.
Synonyms	Nintedanib ethanesulfonate
Chemical Name	(Z)-methyl 3-(((4-(N-methyl-2-(4-methylpiperazin-1-yl) acetamido) phenyl) amino) (phenyl) methylene)-2-oxoindoline-6-carboxylate ethane sulfonate
Common name	Nintedanib esylate
Therapeutic use	Idiopathic pulmonary fibrosis (IPF), Non-small-cell lung cancer
Background	Nintedanib was approved in March 2020 in the United States for use to treat chronic fibrosing (scarring) interstitial lung diseases (ILD) with a progressive phenotype (trait). It is the first treatment for this group of fibrosing lung diseases that worsen over time that was approved by the U.S. Food and Drug Administration (FDA).
Grade	In-house
Polymorph	Form I
GTI	-
Nitrosamines	-
DMF Availability	-
Manufacturing batch size	-
Production capacity	-
Stability data	-

Please Note: We partner exclusively with pharmaceutical manufacturers, biotech companies, and international trading firms. Minimum order quantities apply*

Disclaimer:

The information provided on this webpage is based on the best available knowledge at the time of publication; however, accuracy and completeness are not guaranteed. Product specifications may change without notice. It is the responsibility of the purchaser or user to verify suitability and compliance. This product is intended for research use only and is not approved for human consumption.

Why Shilpa Pharma?

Happy Customers

Projects Successfully Completed

Established

PhD Experts Driving R&D Excellence

Team Size

World-Class API Manufacturing Sites

Global Audits Successfully Completed

Comprehensive CDMO Service Offerings

Our Nintedanib esylate are also Available for

Questions & Answers

FAQ on Nintedanib esylate

Everything You Need to Know About Shilpa Pharma

Shilpa Pharma – Your Trusted Global CDMO Partner

Delivering end-to-end solutions across API oncology, generics, peptides, polymers and specialty chemicals, we empower partners to accelerate development, ensure compliance, and reach markets faster with reliable, cost-effective innovation.